Innospec Inc. (NASDAQ:IOSP) Q3 2020 Results Earnings Conference Call November 4, 2020 9:00 AM ET Company Participants David Jones - General Counsel, Chief Compliance Officer, Corporate Secretary Patrick Williams - President, Chief Executive Officer Ian Cleminson - Executive Vice President, Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities David Silver - C.L. King Chris Shaw - Monness, Crespi Operator Ladies and gentlemen, thank you for standing by and welcome to today's In ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: | | Trading | Name of eac ...

innospec� chemistry matters Q3 2020 Earnings NOVEMBER 2020 Forward Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "estimates," "anticipates," "may," "believes," "feels," "plan," "inte ...

Innospec Inc. (NASDAQ:IOSP) Q2 2020 Earnings Conference Call August 5, 2020 10:00 AM ET Company Participants David Jones - VP, General Counsel, Chief Compliance Officer & Corporate Secretary Patrick Williams - President & CEO Ian Cleminson - EVP & CFO Conference Call Participants David Silver - CL King Capital Jon Tanwanteng - CJS Securities Operator Ladies and gentlemen, thank you for standing by. Welcome to today's Innospec's Second Quarter 2020 Earnings Release Conference Call. At this time, all particip ...

innospec� chemistry matters Q2 2020 Earnings AUGUST 2020 Forward Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "estimates," "anticipates," "may," "believes," "feels," "plan," "intend ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or other jurisdiction ...

Innospec Inc. (NASDAQ:IOSP) Q1 2020 Earnings Conference Call May 6, 2020 9:00 AM ET Company Participants David Jones - VP, General Counsel, Chief Compliance Officer & Corporate Secretary Patrick Williams - President, CEO & Director Ian Cleminson - EVP & CFO Conference Call Participants Jonathan Tanwanteng - CJS Securities Christopher Shaw - Monness, Crespi, Hardt & Co. David Silver - CL King & Associates Bill Dezellem - Tieton Capital David Jones Thank you, everyone. Welcome to Innospec’s first-quarter earn ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or other jurisdiction ...

Innospec, Inc. (NASDAQ:IOSP) Q4 2019 Earnings Conference Call February 19, 2020 9:00 AM ET Company Participants David Jones - VP, General Counsel, Chief Compliance Officer & Corporate Secretary Patrick Williams - President, CEO & Director Ian Cleminson - EVP & CFO Conference Call Participants Jonathan Tanwanteng - CJS Securities Christopher Shaw - Monness, Crespi, Hardt & Co. David Silver - CL King & Associates Operator Ladies and gentlemen, thank you for standing by, and welcome to today's Innospec's Fourt ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) For the fiscal year ended December 31, 2019 or Title of each class Name of each exchange on which reg ...